» Articles » PMID: 37764763

Latent TB Infection, Vitamin D Status and COVID-19 Severity in Mongolian Patients

Overview
Journal Nutrients
Date 2023 Sep 28
PMID 37764763
Authors
Affiliations
Soon will be listed here.
Abstract

We aimed to determine potential risk factors for COVID-19 severity including serum vitamin D levels and latent TB infection among Mongolian inpatients diagnosed with COVID-19, and to study the effects of disease complications and treatment outcomes. This study included patients admitted to the Mongolian National Center for Communicable Disease, a main referral center for infectious disease in Mongolia, with COVID-19 ascertained by a positive PCR test. Patients' demographic, clinical, and laboratory data were analyzed. Of the 270 patients enrolled, 125 (46%) had mild-to-moderate illness, 86 (32%) had severe illness, and 59 (22%) had critical illness. Ten (91%) of the 11 patients who had active TB were hospitalized with severe or critical COVID-19, suggesting that they had a higher risk of falling into the severe category (OR = 10.6 [1.2; 92.0] 95% CI). Severe vitamin D deficiency (25(OH)D < 10 ng/mL) was present in 32% of the patients, but was not significantly associated with the severity of illness ( = 0.65). Older age, being male, having active TB and/or COPD were associated with greater COVID-19 severity, whereas a history of COVID-19 vaccination and the presence of a BCG vaccination scar were protective in terms of disease severity.

Citing Articles

Predicting COVID-19 Re-Positive Cases in Malnourished Older Adults: A Clinical Model Development and Validation.

Chen J, Luo D, Sun C, Sun X, Dai C, Hu X Clin Interv Aging. 2024; 19:421-437.

PMID: 38487375 PMC: 10937181. DOI: 10.2147/CIA.S449338.


Physiological Evidence and Therapeutic Outcomes of Vitamin D on Cardiovascular Diseases.

Zendehdel A, Shakarami A, Moghadam E Curr Cardiol Rev. 2024; .

PMID: 38243935 PMC: 11071673. DOI: 10.2174/011573403X263417231107110618.

References
1.
Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione M . Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J. 2020; 56(1). PMC: 7263070. DOI: 10.1183/13993003.01708-2020. View

2.
Madan M, Baldwa B, Raja A, Tyagi R, Dwivedi T, Mohan A . Impact of Latent Tuberculosis on Severity and Outcomes in Admitted COVID-19 Patients. Cureus. 2021; 13(11):e19882. PMC: 8709920. DOI: 10.7759/cureus.19882. View

3.
Koupaei M, Naimi A, Moafi N, Mohammadi P, Tabatabaei F, Ghazizadeh S . Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review. Front Med (Lausanne). 2021; 8:740593. PMC: 8671757. DOI: 10.3389/fmed.2021.740593. View

4.
Canetti D, Antonello R, Saderi L, Giro M, Goletti D, Sarmati L . Impact of SARS-CoV-2 infection on tuberculosis outcome and follow-up in Italy during the first COVID-19 pandemic wave: a nationwide online survey. Infez Med. 2022; 30(3):418-426. PMC: 9448321. DOI: 10.53854/liim-3003-10. View

5.
Tadolini M, Codecasa L, Garcia-Garcia J, Blanc F, Borisov S, Alffenaar J . Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020; 56(1). PMC: 7251245. DOI: 10.1183/13993003.01398-2020. View